Valvular bronchial blocking in the treatment of cavitary pulmonary tuberculosis (CPTB) Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks Year: 2016
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
MOTT as a cause of treatment failure in pulmonary tuberculosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013
Surgical complications of destructive pulmonary tuberculosis and ways of their correction Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Collapse therapy in cavitary pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Consecutive surgical treatment for bilateral fibro-cavernous pulmonary TB Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Endobronchial valve in complex treatment of patients with destructive pulmonary TB/HIV co-infection Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks Year: 2016
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Treatment of patients with extensive TB and concomitant bronchial lesions with some anti-TB drugs delivered via nebulizer Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005
Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB) Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR) Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Collapse therapy using endobronchial valves as a new approach to treat cavities in MDR tuberculosis and selected cases of mycobacteriosis: Case series report Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015